false
OasisLMS
Catalog
SCCM Resource Library
Pharmacologic Management Strategies
Pharmacologic Management Strategies
Back to course
[Please upgrade your browser to play this video content]
Video Transcription
Video Summary
In this video, the speaker, a professor and pharmacist, discusses prevention and pharmacologic strategies for delirium. The speaker emphasizes that drugs are often the cause of delirium, rather than the solution. The speaker recommends against routine use of benzodiazepines, minimizing sedation strategies whenever possible, and not routine use of haloperidol or atypical antipsychotics for preventing delirium. The speaker also discusses the use of dexmedetomidine as a sedative, noting that it has not been associated with altered sleep patterns like benzodiazepines. There is limited evidence regarding the role of melatonin in preventing delirium, with some studies showing no significant decrease in the development of delirium. The speaker also discusses the use of haloperidol and atypical antipsychotics for severe delirium, but emphasizes the need for baseline EKG and routine electrolyte monitoring due to the drugs' toxicity. The speaker concludes by recommending non-pharmacologic therapy and using drugs with caution and monitoring for adverse effects.
Asset Subtitle
Pharmacology, 2023
Asset Caption
Type: one-hour concurrent | Give Hugs, Not Drugs! Managing Pediatric Delirium (Pediatrics) (SessionID 1208596)
Meta Tag
Content Type
Presentation
Knowledge Area
Pharmacology
Learning Pathway
Delirium and Sedation Managment
Membership Level
Professional
Membership Level
Select
Tag
Pharmacology
Year
2023
Keywords
delirium
pharmacologic strategies
benzodiazepines
sedation strategies
non-pharmacologic therapy
×
Please select your language
1
English